In it to bring leading-edge science to the world.
With more than 20 years of experience in the biotechnology industry, Jean holds deep expertise in legal and business leadership. She oversees all aspects of the legal, compliance, and intellectual property functions at Seagen and serves as Corporate Secretary, advising on strategic matters.
Previously, Jean was the Vice President and General Counsel at Halozyme Therapeutics and the Chief Legal Officer and Corporate Secretary at Durect Corporation. Earlier in her career, Jean was an attorney at Pillsbury, Madison & Sutro (now Pillsbury Winthrop) and Venture Law Group, where she advised early-stage companies on technology transfer, licensing, patents, and copyright and trademark litigation.
Jean holds a J.D. from Columbia University, where she was a Harlan Fiske Stone Scholar. She also earned an M.S. in Biology from Stanford University and a B.S. in Cellular and Molecular Biology with highest distinction from the University of Michigan. She serves as a member of the board of directors for Connect Biopharma Holdings Ltd and Erasca, Inc.